Pulmonary Embolism Anticoagulation in Renal Impairment
A 66-year-old woman with stage 5 chronic kidney disease not on dialysis, estimated glomerular filtration rate 18 mL/min/1.73 m², develops sudden pleuritic chest pain and breathlessness 5 days after elective total hip replacement. CT pulmonary angiography confirms bilateral segmental pulmonary emboli, and echocardiography shows normal right ventricular size and function with a normal troponin. The surgical wound is dry. What is the most appropriate initial anticoagulation?
- A.Rivaroxaban at standard treatment dosing
- B.Full treatment-dose enoxaparin twice daily
- C.Intravenous unfractionated heparin infusionCorrect
- D.Warfarin alone without parenteral bridging
Explanation
This patient has an acute intermediate to low-risk pulmonary embolism and requires immediate anticoagulation, but her severe renal impairment dictates which agent is safe. Low-molecular-weight heparins are cleared almost entirely by the kidney, so with a creatinine clearance below 30 mL/min they accumulate and cause a substantial rise in major bleeding, particularly relevant here because she is 5 days post-arthroplasty. Unfractionated heparin is cleared by a saturable reticuloendothelial and hepatic mechanism rather than by renal excretion, so its half-life is unchanged in kidney disease; it is titrated to an activated partial thromboplastin time ratio of 1.5 to 2.5 or an anti-Xa level, has a short 60 to 90 minute half-life, and can be reversed rapidly with protamine sulfate if bleeding occurs. Those properties make it the agent of choice when renal function is poor, bleeding risk is elevated, or thrombolysis or surgery may be needed at short notice. Direct oral anticoagulants including rivaroxaban and apixaban are not recommended below a creatinine clearance of about 30 and 25 mL/min respectively because of accumulation and exclusion from the pivotal trials. Warfarin without parenteral bridging is unacceptable in acute venous thromboembolism because it takes 5 or more days for factor II to fall and it transiently lowers protein C, creating an early prothrombotic window. Since her right ventricle is normal and she is hemodynamically stable, thrombolysis is not indicated. Anticoagulation should continue for at least 3 months for this provoked event, and if low-molecular-weight heparin is later used at all it must be dose-reduced with anti-Xa monitoring.
Why each option
- A.
- Rivaroxaban is not recommended below a creatinine clearance of about 30 mL/min and was not studied in this population.
- B.
- Full-dose enoxaparin accumulates when creatinine clearance is below 30 mL/min and markedly increases bleeding risk soon after surgery.
- C.
- Correct. Unfractionated heparin is not renally cleared, is titratable and is rapidly reversible, making it the safest choice in severe renal impairment.
- D.
- Warfarin alone provides no immediate anticoagulation and transiently lowers protein C, so parenteral cover is mandatory.
Reference: ESC Guidelines for the Diagnosis and Management of Acute Pulmonary Embolism, 2019; CHEST Antithrombotic Therapy for VTE Disease, 2021 update
This is one of 3,009 questions in the MedBoardSA SMLE bank, with timed test mode, tutor mode, and progress tracking by topic.
Practise the full bank